Novo Holdings a/S
$1.7B 13F equity value
28 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Novo Holdings a/S covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| EWTX | EDGEWISE THERAPEUTICS INC | 5,350,000 | $217M | 12.6% |
| ASML | ASML HOLDING N V | 94,946 | $189M | 11.0% |
| COAG | HEMAB THERAPEUTICS HLDGS INC | 4,180,550 | $154M | 8.9% |
| BN | BROOKFIELD CORP | 3,496,245 | $150M | 8.7% |
| MPLT | MAPLIGHT THERAPEUTICS INC | 3,686,622 | $132M | 7.7% |
| MIRM | MIRUM PHARMACEUTICALS INC | 1,125,000 | $132M | 7.6% |
| AVLN | AVALYN PHARMACEUTICALS INC | 3,883,289 | $128M | 7.4% |
| CRM | SALESFORCE INC | 393,187 | $62M | 3.6% |
| AVBP | ARRIVENT BIOPHARMA INC | 1,500,000 | $52M | 3.0% |
| ELVN | ENLIVEN THERAPEUTICS INC | 1,000,000 | $51M | 2.9% |
Track Novo Holdings a/S's 13F portfolio: $1.7B in reported holdings, 28 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}